• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    6/18/24 1:39:53 PM ET
    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ALAR alert in real time by email

    Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.

    Quantum shares dipped 44.5% to $0.43 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Reliance Global Group, Inc. (NASDAQ:RELI) shares jumped 350% to $1.00 after the company issued an update on the pending acquisition of Spetner Associates.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) shares rose 166% to $0.3930 after jumping 30% on Monday.
    • Actelis Networks, Inc. (NASDAQ:ASNS) climbed 80.9% to $2.08 after the company announced a partnership with Carahsoft Technology Corp.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) rose 65% to $3.5801 after the company announced a new $222 million credit facility.
    • Mustang Bio, Inc. (NASDAQ:MBIO) gained 60.6% to $1.2050. Mustang Bio shares jumped 477% on Monday after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) climbed 39.2% to $0.2342 following fourth-quarter results.
    • Silk Road Medical, Inc (NASDAQ:SILK) jumped 23.8% to $26.83 after the company entered a definitive deal to be acquired by Boston Scientific for $27.50 per share.
    • Mesa Air Group, Inc. (NASDAQ:MESA) gained 23.7% to $1.3990 following upbeat quarterly earnings.
    • Silynxcom Ltd. (NASDAQ:SYNX) gained 20.4% to $3.8826 as the company secured multiple orders from the  US Federal and Law Enforcement Organizations of its new tactical system.
    • La-Z-Boy Incorporated (NYSE:LZB) jumped 17.7% to $40.11.
    • Karooooo Ltd. (NASDAQ:KARO) gained 14.6% to $33.59
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares rose 14.5% to $0.2049 following better-than-expected fourth-quarter earnings.
    • Chegg, Inc. (NYSE:CHGG) rose 14.2% to $2.9811 after the company announced a restructuring plan and new vision for growth.
    • Mynd.ai, Inc. (NASDAQ:MYND) gained 9.7% to $2.7183.
    • Patterson Companies, Inc. (NASDAQ:PDCO) gained 9.7% to $25.06 following quarterly results.
    • Chewy, Inc. (NYSE:CHWY) climbed 9.4% to $24.96
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) rose 9% to $4.7305 after signing a 10-launch deal with Japanese firm Synspective in Tokyo.
    • Toast, Inc. (NYSE:TOST) gained 8.7% to $24.57.
    • e.l.f. Beauty, Inc. (NYSE:ELF) rose 7% to $209.00 after Canaccord Genuity maintained a Buy rating and raised its price target from $214 to $250.

    Losers

    • Solidion Technology Inc. (NASDAQ:STI) shares fell 68.4% to $0.6078.
    • DermTech, Inc. (NASDAQ:DMTK) fell 58.4% to $0.1383 after the company filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
    • Interactive Strength Inc. (NASDAQ:TRNR) shares fell 38.9% to $3.00 after surging 71% on Monday.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares fell 37% to $2.10. Aerwins Technologies named Kiran Sidhu as the company's interim CFO, following resignation of Yinshun He as CFO on June 11. On June 14, the company received final delisting notice from Nasdaq Hearings Panel of Nasdaq Stock Market.
    • Taysha Gene Therapies Inc (NASDAQ:TSHA) shares fell 34.5% to $2.64 after the company announced longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial of TSHA-102 in Rett syndrome.
    • Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) dipped 32.7% to $5.64 after the FDA placed a partial clinical hold on ZN-c3-001, DENALI, and TETON monotherapy studies of Azenosertib following two recent deaths due to presumed sepsis in the DENALI study.
    • Kaival Brands Innovations Group Inc (NASDAQ:KAVL) declined 29% to $2.97
    • Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) shares fell 28.6% to $4.00 after gaining 60% on Monday.
    • Alarum Technologies Ltd – ADR (NASDAQ:ALAR) fell 27.3% to $25.11.
    • Azitra Inc (NYSE:AZTR) dipped 26.2% to $0.16.
    • Autonomix Medical Inc (NASDAQ:AMIX) shares declined 26% to $1.02 as the company announced preliminary results from first five patients in PoC trial for pancreatic cancer pain.
    • Haoxi Health Technology Ltd (NASDAQ:HAO) dipped 19.4% to $4.62.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares declined 18.6% to $0.62 after jumping over 10% on Monday.
    • Cabaletta Bio Inc (NASDAQ:CABA) shares fell 15.3% to $7.93.
    • Neurogene Inc (NASDAQ:NGNE) dipped 15.3% to $33.88. The company announced that the first patient in Cohort 2 received high-dose NGN-401 gene therapy in the Phase 1/2 trial for female pediatric patients with Rett syndrome.
    • Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) fell 15% to $0.72. Polestar Automotive recently announced geographic expansion and plans to enter seven new markets during 2025.
    • Earlyworks Co Ltd – ADR (NASDAQ:ELWS) shares declined 13% to $1.70. Earlyworks regained compliance with Nasdaq Minimum Bid Price Requirement.
    • SRIVARU Holding Limited (NASDAQ:SVMH) shares fell 12.3% to $0.21.
    • Skye Bioscience Inc (NASDAQ:SKYE) dipped 12.3% to $9.52. Cantor Fitzgerald analyst Kristen Kluska reiterated Skye Bioscience with an Overweight and maintained a $14 price target.
    • CureVac BV (NASDAQ:CVAC) declined 9.4% to $3.15.
    • Novavax Inc (NASDAQ:NVAX) fell 6.2% to $13.18.
    • Geron Corp (NASDAQ:GERN) declined 5.4% to $4.42.

    Now Read This: Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $ALAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALAR
    $AMIX
    $ASNS
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Karooooo Ltd.
    $KARO
    2/17/2026$62.00Buy
    Roth Capital
    Toast Inc.
    $TOST
    2/2/2026$42.00 → $36.00Neutral
    DA Davidson
    e.l.f. Beauty Inc.
    $ELF
    1/23/2026$110.00Buy
    Citigroup
    Toast Inc.
    $TOST
    1/20/2026In-line → Outperform
    Evercore ISI
    Rocket Lab Corporation
    $RKLB
    1/16/2026$105.00Equal-Weight → Overweight
    Morgan Stanley
    Rocket Lab Corporation
    $RKLB
    1/15/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Polestar Automotive Holding UK PLC downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Polestar Automotive Holding UK PLC from Neutral to Underweight

    2/19/26 7:50:28 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Chewy upgraded by Raymond James with a new price target

    Raymond James upgraded Chewy from Mkt Perform to Outperform and set a new price target of $28.00

    2/19/26 7:46:41 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Roth Capital initiated coverage on Karooooo Ltd. with a new price target

    Roth Capital initiated coverage of Karooooo Ltd. with a rating of Buy and set a new price target of $62.00

    2/17/26 8:18:44 AM ET
    $KARO
    Computer Software: Prepackaged Software
    Technology

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sr VP & Chief Supply Chain Off Leggett Michael Adam sold $81,400 worth of shares (2,200 units at $37.00), decreasing direct ownership by 5% to 42,473 units (SEC Form 4)

    4 - LA-Z-BOY INC (0000057131) (Issuer)

    2/23/26 5:38:10 PM ET
    $LZB
    Home Furnishings
    Consumer Discretionary

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 4 filed by EVP, R&D; Chief Medical Office Eid Joseph

    4 - GERON CORP (0000886744) (Issuer)

    2/19/26 6:11:23 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Matthew bought $464,814 worth of shares (5,000 units at $92.96), increasing direct ownership by 86% to 10,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/23/26 4:07:34 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel bought $56,360 worth of shares (100,000 units at $0.56), increasing direct ownership by 1% to 7,625,075 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    2/18/26 6:30:27 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    SEC Filings

    View All

    Interactive Strength Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Interactive Strength, Inc. (0001785056) (Filer)

    2/23/26 5:13:06 PM ET
    $TRNR
    Consumer Electronics/Appliances
    Technology

    SEC Form PRE 14A filed by Actelis Networks Inc.

    PRE 14A - ACTELIS NETWORKS INC (0001141284) (Filer)

    2/20/26 4:54:05 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    SEC Form 8-K filed by Skye Bioscience Inc.

    8-K - Skye Bioscience, Inc. (0001516551) (Filer)

    2/20/26 4:05:12 PM ET
    $SKYE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sportstech Brands Holding GmbH Responds to the Shareholder Letter Dated February 20, 2026 from Interactive Strength Inc. (Nasdaq: TRNR) regarding Reverse Split

    BERLIN, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sportstech Brands Holding GmbH refers to the shareholder letter dated February 20, 2026 from Interactive Strength Inc. (NASDAQ:TRNR) in connection with the announced reverse split. The assertion made therein that Sportstech is responsible for TRNR's capital market performance does not reflect the facts. 1. No Responsibility for Share Price or Capital Measures Sportstech unequivocally and categorically rejects the allegations raised by TRNR. In Sportstech's view, the share price performance of a publicly listed company is determined by operational performance, financial metrics, liquidity, capital structure, financing requirements, and general ma

    2/23/26 12:54:21 PM ET
    $TRNR
    Consumer Electronics/Appliances
    Technology

    Geron Plans to Present at Upcoming Investor Conferences

    FOSTER CITY, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that members of the management team are scheduled to present at the following investor conferences: TD Cowen 46th Annual Healthcare ConferenceFireside Chat on Monday, March 2 at 1:10 p.m. ET in Boston, MABarclays 28th Annual Global Healthcare ConferenceFireside Chat on Tuesday, March 10 at 10:30 a.m. ET in Miami, FLLeerink Partners Global Healthcare ConferenceIn-Person Meetings on Wednesday, March 11 in Miami, FL A live and archived audio webcast of each fireside chat will be

    2/23/26 8:00:00 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum

    DENVER, Feb. 19, 2026 (GLOBE NEWSWIRE) -- U.S. equity markets are pointing modestly lower this Thursday morning. The focus remains on earnings season kickoff and any fresh Fed commentary, but today's headlines are dominated by transformative deals and production milestones that are lifting small- and mid-cap names. Key Movers & Catalysts Driving the Tape Interactive Strength (NASDAQ:TRNR) is the standout gainer pre-market, surging more than 40% after announcing a definitive agreement to acquire Ergatta, the game-based connected fitness pioneer. The deal boosts TRNR's 2026 pro forma revenue guidance by 50%, to more than $30 million, with Ergatta alone expected to deliver > $10 million in

    2/19/26 11:00:26 AM ET
    $ELAB
    $TOVX
    $TRNR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Consumer Electronics/Appliances
    Technology

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 19, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 26, 2026. Details of the event and replay are as follows:Conference call details:Date:February 26, 2026Time:8:30 a.m. ETURL to register phone:Register HereDial-in number:(888) 880-3330 (U.S.) or(+1) (646) 357-8766 (International)Webcast:ir.novavax.com/eventsParticipants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.Participants can als

    2/19/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    La-Z-Boy Incorporated Reports Strong Third Quarter Results Led By Double-Digit Retail Sales Growth; Drives Significant Progress On Strategic Initiatives

    Fiscal 2026 Third Quarter Highlights: Delivered sales of $542 million Up 4% versus prior year Retail segment written sales increased 11% and delivered sales increased 11% Opened four new company-owned stores in the quarter and 16 in the last 12 months Wholesale segment delivered sales increased 1% Completed western U.S. phase of distribution and home delivery transformation project GAAP operating margin of 5.5% and adjusted(1) operating margin of 6.1%GAAP diluted EPS of $0.52 and adjusted(1) diluted EPS of $0.61Generated $89 million in operating cash flow for the quarter, a 57% increase versus last year's comparable period Further Progress On Strategic Initiatives: Successfully integrated

    2/17/26 4:15:00 PM ET
    $LZB
    Home Furnishings
    Consumer Discretionary

    Quantum Reports Fiscal Third Quarter 2026 Financial Results

    Quantum Corporation (NASDAQ:QMCO) ("Quantum" or the "Company"), today announced financial results for its fiscal third quarter of 2026 ended December 31, 2025. Fiscal Third Quarter 2026 Financial Summary Revenue was $74.6 million, exceeding the preliminary revenue results of $72.7 million and the original guidance range of $67 million, plus or minus $2.0 million Higher than expected revenue was primarily driven by strong shipments into quarter-end, and to a lesser extent, conservative assumptions related to deferred revenue contracts GAAP operating expenses were $30.1 million; non-GAAP adjusted operating expenses were $26.9 million, reflecting a year-over-year reduction of over $

    2/17/26 4:05:00 PM ET
    $QMCO
    Electronic Components
    Technology

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Chegg Appoints Karine Allouche as General Manager, Language Learning, Worldwide and Skills Integration, Europe

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that Karine Allouche will join Busuu, Chegg's language learning business, as General Manager of Language Learning, Worldwide, and Skills Integration, Europe, effective February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209423954/en/Karine Allouche In her role, Karine will focus on strengthening execution, accelerating growth, and deepening collaboration across the company, in partnership with Chegg's leadership team and the board. In addition to leading language learning, Karine will own Chegg's European commercial engine and play a key role in

    2/9/26 9:05:00 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Quantum Appoints William H. White as Chief Financial Officer

    Seasoned finance executive brings growth-focused mindset to advancing Quantum's long-term strategy Quantum Corporation (NASDAQ:QMCO) today announced the appointment of William H. White as its Chief Financial Officer. White will lead Quantum's global finance organization, including financial strategy and operations, capital structure initiatives, and investor relations, supporting the company's next phase of growth and operational execution. White brings more than two decades of experience transforming technology companies through disciplined financial leadership and strategic capital allocation. He is recognized for improving operational rigor and modernizing reporting and forecasting p

    2/2/26 8:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by Neurogene Inc.

    SC 13G - Neurogene Inc. (0001404644) (Subject)

    12/11/24 4:05:09 PM ET
    $NGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care